{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:35Z","timestamp":1790932175049,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.05.014","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:49:22Z","timestamp":1590097762000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits"],"prefix":"10.1016","volume":"18","author":[{"given":"Liujiang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn J.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telmo","family":"Llanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyn H.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Gilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.05.014_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.omtm.2020.05.014_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.05.014_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004390050641","article-title":"Incidence of the mucopolysaccharidoses in Northern Ireland","volume":"101","author":"Nelson","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtm.2020.05.014_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2020.05.014_bib5","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/OPTH.S78368","article-title":"Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses","volume":"9","author":"Fenzl","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.omtm.2020.05.014_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM197504102921520","article-title":"Letter: corneal cloudiness and retinitis pigmentosa in the mucopolysaccharidoses","volume":"292","author":"Cotlier","year":"1975","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.05.014_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2016.05.022","article-title":"A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome","volume":"148","author":"Yuan","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtm.2020.05.014_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0161-6420(89)32795-3","article-title":"Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report","volume":"96","author":"Summers","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2020.05.014_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archophthalmol.2010.341","article-title":"Outcome of penetrating keratoplasty for mucopolysaccharidoses","volume":"129","author":"Bothun","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.omtm.2020.05.014_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.survophthal.2016.12.010","article-title":"Management of high-risk corneal transplantation","volume":"62","author":"Di Zazzo","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.omtm.2020.05.014_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bjophthalmol-2016-308807","article-title":"Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective","volume":"101","author":"Ohden","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omtm.2020.05.014_bib12","doi-asserted-by":"crossref","first-page":"22131","DOI":"10.1038\/srep22131","article-title":"AAV gene therapy for MPS1-associated corneal blindness","volume":"6","author":"Vance","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.05.014_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2020.04.004","article-title":"Intrastromal gene therapy prevents and reverses advanced corneal clouding in a canine model of mucopolysaccharidosis I","author":"Miyadera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.05.014_bib14","series-title":"Ocular Pharmacology and Toxicology. Methods in Pharmacology and Toxicology","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/7653_2013_2","article-title":"Selection of appropriate animal models in ocular research: ocular anatomy and physiology of common animal models","author":"Gilger","year":"2013"},{"key":"10.1016\/j.omtm.2020.05.014_bib15","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1073\/pnas.81.20.6466","article-title":"Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells","volume":"81","author":"Hermonat","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.05.014_bib16","doi-asserted-by":"crossref","first-page":"17840","DOI":"10.1038\/s41598-017-18002-9","article-title":"AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis","volume":"7","author":"Hirsch","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.05.014_bib17","first-page":"3684971","article-title":"Age-related variations of rabbit corneal geometrical and clinical biomechanical parameters","volume":"2017","author":"Zhang","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtm.2020.05.014_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1746-6148-8-138","article-title":"Reproducibility and age-related changes of ocular parametric measurements in rabbits","volume":"8","author":"Riau","year":"2012","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.omtm.2020.05.014_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fmicb.2012.00182","article-title":"Gene therapy research at the frontiers of viral immunology","volume":"3","author":"Hoffman","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtm.2020.05.014_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.omtm.2020.05.014_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13052-018-0559-9","article-title":"Ocular features in mucopolysaccharidosis: diagnosis and treatment","volume":"44","author":"Del Longo","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.omtm.2020.05.014_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/ICO.0000000000002182","article-title":"A fixed-depth microneedle enhances reproducibility and safety for corneal gene therapy","volume":"39","author":"Gilger","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.omtm.2020.05.014_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/gt.2015.69","article-title":"Prediction of adeno-associated virus neutralizing antibody activity for clinical application","volume":"22","author":"Wang","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.014_bib24","series-title":"Dermatoxicology","first-page":"299","article-title":"Ophthalmic toxicology and assessing ocular irritation","volume":"Fifth Edition","author":"Hackett","year":"1996"},{"key":"10.1016\/j.omtm.2020.05.014_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41434-018-0035-6","article-title":"Serotype survey of AAV gene delivery via subconjunctival injection in mice","volume":"25","author":"Song","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.014_bib26","doi-asserted-by":"crossref","first-page":"e58757","DOI":"10.1371\/journal.pone.0058757","article-title":"High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in\u00a0vitro and in a murine xenograft model in\u00a0vivo","volume":"8","author":"Song","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.05.014_bib27","series-title":"Corneal Regeneration: Methods and Protocols","article-title":"Preparation and administration of adeno-associated virus vectors for corneal gene delivery","author":"Song","year":"2020"},{"key":"10.1016\/j.omtm.2020.05.014_bib28","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1089\/hum.2019.071","article-title":"Gene delivery to human limbal stem cells using viral vectors","volume":"30","author":"Song","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.05.014_bib29","doi-asserted-by":"crossref","first-page":"19864","DOI":"10.1038\/s41598-019-56462-3","article-title":"AAV-mediated expression of HLA-G1\/5 reduces severity of experimental autoimmune uveitis","volume":"9","author":"Crabtree","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2020.05.014_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mt.2015.134","article-title":"Development of patient-specific aav vectors after neutralizing antibody selection for enhanced muscle gene transfer","volume":"24","author":"Li","year":"2016","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:52Z","timestamp":1762421152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S2329050120301017"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.014","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}